We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

131 hedge funds and large institutions have $1.24B invested in Aegerion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 50 increasing their positions, 29 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

72% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 29

13% more capital invested

Capital invested by funds: $1.09B → $1.24B (+$144M)

2% more funds holding

Funds holding: 129 → 131 (+2)

6% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 32

39% less call options, than puts

Call options by funds: $32M | Put options by funds: $52.3M

Holders
131
Holders Change
+2
Holders Change %
+1.55%
% of All Funds
3.8%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.12%
New
34
Increased
50
Reduced
29
Closed
32
Calls
$32M
Puts
$52.3M
Net Calls
-$20.2M
Net Calls Change
-$26.2M

Top Buyers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
+$65.9M
2
Bank of America
Bank of America
North Carolina
+$18.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.6M
4
HM
HealthCor Management
New York
+$14.4M
5
Morgan Stanley
Morgan Stanley
New York
+$13.8M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$38M
2
BBA
Baker Bros. Advisors
New York
-$13.3M
3
TCM
Tamarack Capital Management
California
-$11.7M
4
PHS
PFM Health Sciences
California
-$10.8M
5
FAM
Fred Alger Management
New York
-$6.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
76
Soros Fund Management
New York
$835K +$776K +25,000 New
California Public Employees Retirement System
77
California Public Employees Retirement System
California
$784K – – –
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
$776K – – –
NFA
79
Nationwide Fund Advisors
Ohio
$762K -$641K -20,658 -48%
EAM
80
Eventide Asset Management
Massachusetts
$668K – – –
VRS
81
Virginia Retirement Systems
Virginia
$664K +$618K +19,900 New
WT
82
Whittier Trust
California
$645K – – –
AIG
83
American International Group
New York
$643K -$466 -15 -0.1%
Wellington Management Group
84
Wellington Management Group
Massachusetts
$618K +$574K +18,500 New
VOYA Investment Management
85
VOYA Investment Management
Georgia
$609K – – –
DekaBank Deutsche Girozentrale
86
DekaBank Deutsche Girozentrale
Germany
$576K +$9.31K +300 +2%
OC
87
Oppenheimer & Co
New York
$564K +$525K +16,900 New
CCI
88
Columbus Circle Investors
$556K +$40.7K +1,310 +9%
AIM
89
Assured Investment Management
New York
$436K +$405K +13,054 New
FM
90
Forward Management
California
$404K -$1.51M -48,600 -80%
PNC Financial Services Group
91
PNC Financial Services Group
Pennsylvania
$373K +$6.21K +200 +2%
GAM
92
Gotham Asset Management
New York
$366K +$340K +10,964 New
Nomura Holdings
93
Nomura Holdings
Japan
$347K -$26K -838 -7%
STC
94
SEI Trust Company
Pennsylvania
$337K +$313K +10,100 New
BLM
95
Bennett Lawrence Management
New York
$325K +$302K +9,745 New
LCM
96
Laurion Capital Management
New York
$264K +$245K +7,900 New
NCCM
97
Nine Chapters Capital Management
New Jersey
$257K +$239K +7,700 New
Credit Agricole
98
Credit Agricole
France
$254K -$93.1K -3,000 -28%
AIS
99
AlphaOne Investment Services
Pennsylvania
$235K +$218K +7,028 New
Mackenzie Financial
100
Mackenzie Financial
Ontario, Canada
$210K +$196K +6,300 New
2 3
4
5 6

AEGR Hedge Fund Activity: Q3 2014 in Review

131 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q3 2014, worth a combined $1.24B — up 13% from $1.09B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new AEGR positions and 32 closed out — a net gain of 2 holders — while 50 added to existing stakes and 29 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $65.9M. The largest seller was Lord, Abbett & Co, cutting an estimated $38M.

  • 131 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q3 2014, up from 129 in Q2 2014.
  • Funds reported $1.24B of Aegerion Pharmaceuticals stock for Q3 2014, up 13% quarter-over-quarter.
  • 34 funds opened new Aegerion Pharmaceuticals positions in Q3 2014 and 32 closed out, a net change of +2 holders.
  • The largest Aegerion Pharmaceuticals buyer in Q3 2014 was Scopia Capital Management, an estimated $65.9M added.
  • The largest Aegerion Pharmaceuticals seller in Q3 2014 was Lord, Abbett & Co, an estimated $38M sold.

Based on aggregated 13F filings for Q3 2014.